T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 | +$3B | |
| 2 | +$1.34B | |
| 3 | +$1.26B | |
| 4 |
NVIDIA
NVDA
|
+$1.09B |
| 5 |
Broadcom
AVGO
|
+$1.05B |
Top Sells
| 1 | +$1.18B | |
| 2 | +$1.13B | |
| 3 | +$1.06B | |
| 4 |
Microsoft
MSFT
|
+$1.05B |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$961M |
Sector Composition
| 1 | Technology | 27.68% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 13.58% |
| 4 | Financials | 10.5% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$636B
| $1.23B | 0.75% |
3,603,835
+1,838,198
|
|
||
27
Hilton Worldwide
HLT
$65.1B
| $1.18B | 0.72% |
4,535,244
-1,652,410
|
|
||
28
Veeva Systems
VEEV
$39.7B
| $1.16B | 0.71% |
3,904,655
-527,486
|
|
||
29
TechnipFMC
FTI
$18.9B
| $1.15B | 0.7% |
29,062,796
-5,566,756
|
|
||
30
Mastercard
MA
$497B
| $1.09B | 0.67% |
1,918,451
+1,138,693
|
|
||
31
Cigna
CI
$72.2B
| $1.08B | 0.66% |
3,741,844
+2,342,119
|
|
||
32
Cytokinetics
CYTK
$7.91B
| $1.05B | 0.64% |
19,080,496
+1,478,056
|
|
||
|
33
Broadcom
AVGO
$1.8T
| $1.05B | 0.64% |
3,178,242
+3,173,408
|
|
||
34
Agilent Technologies
A
$42.2B
| $1.05B | 0.64% |
8,148,047
-13,648
|
|
||
35
Starbucks
SBUX
$99.1B
| $992M | 0.61% |
11,722,307
+1,163,508
|
|
||
|
36
Alnylam Pharmaceuticals
ALNY
$62.5B
| $991M | 0.61% |
2,173,984
-2,107,295
|
|
||
37
Willis Towers Watson
WTW
$30.3B
| $981M | 0.6% |
2,840,993
+966,357
|
|
||
38
Workday
WDAY
$56.5B
| $974M | 0.6% |
4,047,252
-1,325,862
|
|
||
39
Tyler Technologies
TYL
$19.9B
| $965M | 0.59% |
1,843,690
+181,699
|
|
||
40
Liberty Live Group Series C
LLYVK
$7.45B
| $947M | 0.58% |
9,764,080
+793,954
|
|
||
41
Planet Fitness
PLNT
$9B
| $943M | 0.58% |
9,086,670
+208,238
|
|
||
42
Liberty Media Series C
FWONK
$23.1B
| $897M | 0.55% |
8,586,261
+257,618
|
|
||
43
ESAB
ESAB
$6.84B
| $889M | 0.54% |
7,960,397
+38,847
|
|
||
44
DTE Energy
DTE
$27.7B
| $872M | 0.53% |
6,166,539
+2,401,221
|
|
||
45
Domino's
DPZ
$14.6B
| $864M | 0.53% |
2,000,781
+65,576
|
|
||
46
Ionis Pharmaceuticals
IONS
$13.3B
| $861M | 0.53% |
13,156,929
-2,891,792
|
|
||
47
Mettler-Toledo International
MTD
$29.3B
| $845M | 0.52% |
688,408
+139,562
|
|
||
48
Assurant
AIZ
$11.1B
| $836M | 0.51% |
3,860,539
-137,974
|
|
||
49
Eli Lilly
LLY
$925B
| $835M | 0.51% |
1,094,696
+93,659
|
|
||
50
Cheniere Energy
LNG
$44.9B
| $823M | 0.5% |
3,503,744
-614,026
|
|